NPPB and type 2 diabetes mellitus: In summary, in a cohort of Chinese individuals with type 2 diabetes, we showed that NT-proBNP was an independent predictor of cardiovascular and renal endpoints, and improved risk stratification of cardiorenal endpoints beyond that provided by clinical risk equations.